Coronavirus Live News Updates: Supreme Court directs AIIMS to postpone INI CET 2021 by one month

[email protected] June 11, 2021 No Comments

June 11, 2021 – 14:07 (IST)

Coronavirus live updates

Restrictions to continue in 11 Karnataka districts, relaxations in other districts from 14 June

The Karnataka government issued revised guidelines easing curbs in all except 11 districts in the state, from 6 am on 14 June to 6 am on 21 June. Shops selling essentials and animal fodder, ODS shops and street vendors will be allowed to operate from  6 am to 2 pm. Parkas have been permitted to open from 5 am to 10 am for walking and jogging with adherence to COVID-19 protocol but group activities will not be permitted.Night curfew will continue between 7 pm to 5 am and weekend curfew will continue from 7 pm on Friday to 5 on Monday, The government also laid out the guidelines for the weekend nad night curfew.

June 11, 2021 – 13:51 (IST)

Coronavirus live updates

Biophore applies to DCGI for emergency-use approval for COVID treatment drug

Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining emergency-use approval for Aviptadil, used in the treatment of moderate to severe cases of COVID-19. The Hyderabad-based firm said it has developed the product which is backward integrated with its in-house API (Active Pharmaceutical Ingredient). The company plans to commence commercial production of the product immediately after the approval is received, it added.
Aviptadil is a synthetic form of Vasoactive Intestinal Peptide (VIP) that, when administered, results in rapid clinical recovery in patients with severe SARS-COV-2 infection. These observations are based on results of multiple trials of Aviptadil against COVID-19 globally in patients with respiratory failure and the same have been submitted to DCGI for their review.

June 11, 2021 – 13:34 (IST)

Coronavirus live updates

Uttarakhand cancels Class 12 board exams

Uttarakhand government cancels Class 12 state board examinations, in view of COVID-19 situation, reports news agency ANI.

June 11, 2021 – 13:27 (IST)

Coronavirus live updates

SC directs postponement of INI CET 2021 by a month

The Supreme Court on Friday directed the All India Institute of Medical Sciences (AIIMS) to postpone the INI CET 2021 exam for at least a month, in view of the COVID-19 situation, reports LiveLaw. 

“Considering that many of the candidates intending to appear in the exam are in covid duty and in remote areas, we are of the opinion that June 16 date is arbitrary. We direct the exam to be postponed by one month, Needless to say exam can be held anytime after the expiry of one month,” Bar&Bench quotes the top court as saying. 

The exam was scheduled to be held on 16 June. The INI CET Exam is conducted for admissions to higher studies in the field of medicine/post graduate studies.

June 11, 2021 – 13:09 (IST)

Coronavirus live updates

US FDA had earlier communicated that no new EUAs will be given for COVID vaccines, says Bharat Biotech

On US FDA rejecting Ocugen’s EUA application for Bharat Biotech’s Covaxin, the Hyderabad-based firm said the FDA Had earlier communicated that no new EUAs will be approved for COVID-19 vaccines. “With good herd immunity and significant percentage of the population vaccinated, the pandemic is reducing in the United States. The US FDA had earlier communicated that no new EUA’s will be approved for covid vaccines.  All applications have to follow the biological license application process, with is the standard process for vaccines. Data from an additional clinical trial will be required to support the marketing application submission for Covaxin,” Bharat Biotech said.
The company also claimed that no vaccine manufactured or developed from India has ever received EUA or full licensure from US FDA.  It added that Covaxin has received EUA’s from 14 countries with more than 50 countries in process. “When approved, it will be a Great Leap Forward for vaccines Innovation and manufacturing from India,” Bharat Biotech said.

June 11, 2021 – 12:38 (IST)

Coronavirus live updates

US FDA rejects EUA for Covaxin, ‘suggests’ Biologics Licence Application route for approval 

 In a setback to Bharat  Biotech’s COVID-19 vaccine Covaxin, the US Food and Drug Administration has “recommended” Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data, nixing hopes of Emergency Use Authorisation.
Ocugen in a statement on Thursday announced that as recommended by the FDA,it will pursue submission of a biologics licence application (BLA) for Covaxin. BLA is a “full approval” mechanism by the FDA for drugs and vaccines.

June 11, 2021 – 12:32 (IST)

Coronavirus live updates

India records 91,702 new COVID-19 cases, 3,403 fresh fatalities

The daily COVID-19 count in India remained below the one-lakh mark for the fourth consecutive day with the country reporting 91,702 fresh cases, while the daily positivity rate dropped to 4.49 percent, according to the Union Health Ministry data updated on Friday. With the fresh cases, the total tally of cases has climbed to 2,92,74,823. The COVID-19 toll climbed to 3,63,079 with 3,403 fresh deaths, the data updated at 8 am showed

The active cases further declined to 11,21,671 comprising 3.83 percent of the total infections, while the national COVID-19 recovery rate has improved to 94.93 percent. A net decline of 46,281 cases has been recorded in the COVID-19 caseload in a span of 24 hours.

PTI

Read More | Source: Firstpost

Leave a Reply

Your email address will not be published. Required fields are marked *